Skip to main content
Top
Published in: Breast Cancer Research 1/2000

01-12-2001 | Paper Report

Multigene expression patterns predict metastatic behavior

Author: Karen L Schmeichel

Published in: Breast Cancer Research | Issue 1/2000

Login to get access

Excerpt

Comparative gene expression analysis of clinically derived breast cancer specimens or established breast cancer cell lines is a promising approach for the identification of critical breast-cancer-related gene clusters. The aim of this study was to use array technology to identify patterns that could be predictive for a specific metastatic behavior (i.e. weakly or highly invasive), as measured by a number of in vitro assays. As proof-of-principle for future diagnostic scenarios, the authors proposed to test the predictive capacity of these "consensus expression profiles" in the context of other breast cancer cell lines whose metastatic behavior had not been systematically characterized in vitro. …
Literature
1.
go back to reference Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu H-L, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res . 2001, 61: 5168-5178.PubMed Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu H-L, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH: Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res . 2001, 61: 5168-5178.PubMed
Metadata
Title
Multigene expression patterns predict metastatic behavior
Author
Karen L Schmeichel
Publication date
01-12-2001
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 1/2000
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr-2001-68467

Other articles of this Issue 1/2000

Breast Cancer Research 1/2000 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine